Executive summary: Nicotine addiction

Drugs of Today

Volumn 41, Issue 6, 2005, Pages 419-425

  Graul, Ann I ^a   Prous, J R ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO N [[3 (4 CHLOROPHENYL) 4 PHENYL 2 PYRAZOLIN 1 YL](METHYLAMINO)METHYLENE]BENZENESULFONAMIDE; AMFEBUTAMONE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CEE 03 310; CLONIDINE; COMMIT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GW 468816; MECAMYLAMINE; NALTREXONE; NICOGUM; NICOPASS; NICOPATCH; NICOTINE; NICOTINE GUM; NICOTINE MDTS; NICOTINE QBETA; NICOTINE VACCINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NIQUITIN CQ; NIQUITIN CQ CLEAR; OPIATE RECEPTOR; RIMONABANT; SELEGILINE; SLV 326; SSR 591813; TA NIC; THE STRAW; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VACCINE; VARENICLINE;

ADDICTION; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; REVIEW; SMOKING CESSATION; SUBSTITUTION THERAPY; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

HUMANS; NICOTINE; NICOTINIC AGONISTS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 23044507093     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.6.914907     Document Type: Review

References (18)

1. Feng, Y., Niu, T., Xing, H. et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 2004, 75: 112.
2. Munafo, M., Clark, T., Johnstone, E., Murphy, M., Walton, R. The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob Res 2004, 6: 583.
3. Parrott, S., Godfrey, C. Economics of smoking cessation. BMJ 2004, 328: 947.
4. Levin, E.D., Rezvani, A.H., Montoya, D., Rose, J.E., Swartzwelder, H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology (Berlin) 2003, 169: 141.
5. Molyneux, A. Nicotine replacement therapy. BMJ 2004, 328: 454-6.
6. Cryan, J.F., Gasparini, F., van Heeke, G., Markou, A. Non-nicotinic neuropharmacological strategies for nicotine dependence: Beyond bupropion. Drug Discov Today 2003, 8: 1025.
7. Holmes, S., Zwar, N., Jimenez-Ruiz, C.A. et al. Bupropion as an aid to smoking cessation: A review of real-life effectiveness. Int J Clin Pract 2004, 58: 285.
8. Lerman, C., Patterson, F., Berrettini, W. Treating tobacco dependence: State of the science and new directions. J Clin Oncol 2005, 23: 311.
9. Roddy, E. Bupropion and other non-nicotine pharmacotherapies. BMJ 2004, 328: 509.
10. George, T.P., O'Malley, S.S. Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 2004, 25: 42.
11. Mansvelder, H.D., De Rover, M., McGehee, D.S., Brussard, A.B. Cholinergic modulation of dopaminergic reward areas: Upstream and downstream targets of nicotine addiction. Eur J Pharmacol 2003, 480: 117.
12. Le Foll, B., Goldberg, S.R. Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 2005, 312: 875.
13. Filozof, C., Fernandez Pinilla, M.C., Fernandez-Cruz, A. Smoking cessation and weight gain. Obes Rev 2004, 5: 95.
14. Laviolette, S.R., Van Der Kooy, D. The neurobiology of nicotine addiction: Bridging the gap from molecules to behavior. Nat Rev Neurosci 2004, 5: 55.
15. Houtsmuller, E.J., Thornton, J.A., Stitzer, M.L. The effects of selegiline (I-deprenyl) during smoking and short-term abstinence. Psychopharmacology (Berlin) 2002, 163: 213.
16. Carrera, M.R. et al. Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorg Med Chem 2003, 12: 563.
17. Cerny, T. Anti-nicotine vaccination: Where are we? Recent Results Cancer Res 2005, 166: 167.
18. Pentel, P., Malin, D. A vaccine for nicotine dependence: Targeting the drug rather than the brain. Respiration 2002, 69: 193.